STOCK TITAN

Erasca, Inc. Financials

ERAS
FY2025 annual
Revenue Not reported for FY2025
Net Income -$124.5M +23.0% YoY
EPS (Diluted) -$0.44 +36.2% YoY
Free Cash Flow -$95.6M +12.7% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

This page shows Erasca, Inc. (ERAS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ERAS FY2025

An R&D-heavy balance sheet is buying time, while cash burn still mirrors the loss line rather than easing.

Across the last three years, operating cash outflow stayed clustered near -$100M even as the net loss improved to -$124.5M in the latest year. That is why the key financing event was the earlier $240.7M financing inflow rather than the latest year's $1.1M, so the balance sheet is still drawing on past fundraising.

Short-term solvency looks comfortable: current assets were $286.2M versus current liabilities of $28.5M. That cushion means pressure comes more from funding research than from creditors; even so, cash at $73.8M sits below the latest year's operating cash use of -$95.5M.

The cost base remains overwhelmingly research-led: R&D expense was $92.9M against SG&A of $38.6M. That mix makes the smaller loss better read as a change in development pacing than as evidence of a self-funding operating model.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Erasca, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/6

Erasca, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing
N/A

Erasca, Inc. reported a net loss of $124.5M while operations used $95.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA
-$137.8M
YoY+21.6%

Erasca, Inc.'s EBITDA was -$137.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 21.6% from the prior year.

Net Income
-$124.5M
YoY+23.0%

Erasca, Inc. reported -$124.5M in net income in fiscal year 2025. This represents an increase of 23.0% from the prior year.

EPS (Diluted)
-$0.44
YoY+36.2%

Erasca, Inc. earned -$0.44 per diluted share (EPS) in fiscal year 2025. This represents an increase of 36.2% from the prior year.

Revenue

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$95.6M
YoY+12.7%

Erasca, Inc. recorded an outflow of $95.6M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 12.7% from the prior year.

Cash & Debt
$73.8M
YoY+9.0%
5Y CAGR+2.5%

Erasca, Inc. held $73.8M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share
$0.00

Erasca, Inc. paid $0.00 per share in dividends in fiscal year 2025.

Shares Outstanding
284M
YoY+0.3%

Erasca, Inc. had 284M shares outstanding in fiscal year 2025. This represents an increase of 0.3% from the prior year.

Margins & Returns

Return on Equity
-38.3%
YoY-0.1pp

Erasca, Inc.'s ROE was -38.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.1 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$92.9M
YoY-19.5%
5Y CAGR+25.7%

Erasca, Inc. invested $92.9M in research and development in fiscal year 2025. This represents a decrease of 19.5% from the prior year.

Capital Expenditures
$128K
YoY+113.3%
5Y CAGR-33.0%

Erasca, Inc. invested $128K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 113.3% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

ERAS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ERAS annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20
R&D ExpensesN/A$92.9M-19.5%$115.4M+11.1%$103.8M-7.7%$112.5M+52.1%$73.9M+150.2%$29.6M
SG&A ExpensesN/A$38.6M-7.6%$41.7M+10.7%$37.7M+14.3%$33.0M+45.9%$22.6M+184.2%$8.0M
Operating IncomeN/A-$140.9M+21.5%-$179.6M-26.9%-$141.5M+42.8%-$247.4M-98.1%-$124.9M-14.3%-$109.3M
Income TaxN/A$0$0N/AN/AN/AN/A
Net IncomeN/A-$124.5M+23.0%-$161.7M-29.3%-$125.0M+48.5%-$242.8M-97.8%-$122.8M-20.8%-$101.7M
EPS (Diluted)-$0.44+36.2%-$0.69-$0.83+58.3%-$1.99-$1.85N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

ERAS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ERAS annual balance sheet
MetricFY25FY24FY23FY22FY21FY20
Total Assets$396.2M-21.2%$502.5M+27.1%$395.3M-23.2%$514.9M+2.7%$501.4M+301.7%$124.8M
Current Assets$286.2M-7.3%$308.8M-3.7%$320.7M-27.9%$444.5M+5.8%$420.0M+250.0%$120.0M
Cash & Equivalents$73.8M+9.0%$67.7M-27.2%$93.1M-67.3%$284.2M-21.2%$360.5M+451.4%$65.4M
Total Liabilities$71.0M-10.2%$79.0M+0.5%$78.6M-23.7%$103.1M+129.6%$44.9M-81.2%$238.8M
Current Liabilities$28.5M-9.2%$31.4M+20.0%$26.2M-46.3%$48.7M+85.7%$26.2M+91.7%$13.7M
Total Equity$325.2M-23.2%$423.5M+33.7%$316.7M-23.1%$411.9M-9.8%$456.5M+500.5%-$114.0M
Retained Earnings-$892.2M-16.2%-$767.7M-26.7%-$606.0M-26.0%-$481.0M-101.9%-$238.2M-106.4%-$115.4M

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

ERAS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ERAS annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20
Operating Cash Flow-$98.0M-$95.5M+12.8%-$109.4M-8.1%-$101.2M+2.0%-$103.3M-29.7%-$79.6M-143.5%-$32.7M
Capital Expenditures$59K$128K+113.3%$60K-96.6%$1.8M-87.8%$14.6M+29.9%$11.2M+1083.2%$947K
Free Cash Flow-$98.1M-$95.6M+12.7%-$109.5M-6.3%-$103.0M+12.6%-$117.8M-29.7%-$90.8M-170.0%-$33.6M
Investing Cash Flow-$173.9M$100.4M+164.1%-$156.6M-71.7%-$91.2M-28.3%-$71.1M-10.0%-$64.6M+9.3%-$71.2M
Financing Cash Flow$248.3M$1.1M-99.5%$240.7M+18486.6%$1.3M-98.7%$98.1M-77.7%$439.4M+213.9%$140.0M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

ERAS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ERAS annual financial ratios
MetricFY25FY24FY23FY22FY21FY20
Return on Equity-38.3%-0.1pp-38.2%+1.3pp-39.5%+19.5pp-59.0%-32.1pp-26.9%N/A
Return on Assets-31.4%+0.7pp-32.2%-0.5pp-31.6%+15.5pp-47.1%-22.7pp-24.5%+57.0pp-81.4%
Current Ratio10.04+0.2x9.84-2.4x12.26+3.1x9.13-6.9x16.02+7.2x8.77
Debt-to-Equity0.220.0x0.19-0.1x0.250.0x0.25+0.2x0.10N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

Is Erasca, Inc. profitable?

No, Erasca, Inc. (ERAS) reported a net income of -$124.5M in fiscal year 2025.

What is Erasca, Inc.'s earnings per share (EPS)?

Erasca, Inc. (ERAS) reported diluted earnings per share of -$0.44 for fiscal year 2025. This represents a 36.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Erasca, Inc.'s EBITDA?

Erasca, Inc. (ERAS) had EBITDA of -$137.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Erasca, Inc. (ERAS) has a return on equity of -38.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Erasca, Inc. (ERAS) recorded an outflow of $95.6M in free cash flow during fiscal year 2025. This represents a 12.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Erasca, Inc. (ERAS) recorded an outflow of $95.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Erasca, Inc. (ERAS) had $396.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Erasca, Inc. (ERAS) invested $128K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Erasca, Inc. (ERAS) invested $92.9M in research and development during fiscal year 2025.

Erasca, Inc. (ERAS) had 284M shares outstanding as of fiscal year 2025.

Erasca, Inc. (ERAS) had a current ratio of 10.04 as of fiscal year 2025, which is generally considered healthy.

Erasca, Inc. (ERAS) had a debt-to-equity ratio of 0.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Erasca, Inc. (ERAS) had a return on assets of -31.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Erasca, Inc. (ERAS) had $73.8M in cash against an annual operating cash burn of $95.5M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Erasca, Inc. (ERAS) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Erasca, Inc. (ERAS) reported a net loss of $124.5M while operations used $95.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top